| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,875 |
16,414 |
$1.26M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,887 |
4,277 |
$372K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,620 |
4,885 |
$349K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,252 |
2,080 |
$150K |
| S9083 |
Global fee urgent care centers |
1,374 |
1,190 |
$143K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,399 |
2,354 |
$76K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,084 |
4,123 |
$60K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,999 |
3,599 |
$40K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
636 |
467 |
$38K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,469 |
1,182 |
$31K |
| 99215 |
Prolong outpt/office vis |
197 |
160 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,701 |
2,449 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,989 |
1,594 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
76 |
62 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
36 |
33 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,539 |
1,156 |
$746.27 |
| 0011A |
|
33 |
31 |
$436.08 |
| 81003 |
|
569 |
453 |
$416.57 |
| 0012A |
|
18 |
18 |
$398.32 |
| 87807 |
|
108 |
79 |
$366.55 |
| 81025 |
|
101 |
88 |
$234.81 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
310 |
236 |
$222.81 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
55 |
32 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
133 |
84 |
$0.00 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
64 |
57 |
$0.00 |